Opdivo 240 mg/24 mL injection for intravenous use Images

Generic Name: nivolumab

This medication has been identified as Opdivo 240 mg/24 mL injection for intravenous use. It is supplied by Bristol-Myers Squibb Company.

Opdivo is used in the treatment of Head and Neck Cancer; Esophageal Carcinoma; Hepatocellular Carcinoma; Colorectal Cancer; Gastric Cancer and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Opdivo 240 mg/24 mL injection for intravenous use is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Opdivo

Generic Name

nivolumab

Strength

240 mg/24 mL injection for intravenous use

Availability

Prescription only

Drug Class

Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

CSA Schedule

Not a controlled drug

Labeler / Supplier

Bristol-Myers Squibb Company

National Drug Code (NDC)

00003-3734

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer